295 related articles for article (PubMed ID: 14506129)
41. Expression of the endogenous, nicotinic acetylcholine receptor ligand, SLURP-1, in human colon cancer.
Pettersson A; Nordlander S; Nylund G; Khorram-Manesh A; Nordgren S; Delbro DS
Auton Autacoid Pharmacol; 2008 Oct; 28(4):109-16. PubMed ID: 18764860
[TBL] [Abstract][Full Text] [Related]
42. A novel homozygous mutation disrupting the initiation codon in the SLURP1 gene underlies mal de Meleda in a consanguineous family.
Shah K; Nasir A; Irfanullah ; Shahzad S; Khan S; Ahmad W
Clin Exp Dermatol; 2016 Aug; 41(6):675-679. PubMed ID: 29226984
[TBL] [Abstract][Full Text] [Related]
43. A novel mutation in SLURP1 in patients with mal de Meleda from the Indian subcontinent.
Nellen RG; Claessens T; Subramaniam R; Betkerur J; Prashanth A; Steijlen PM; van Geel M
J Dermatol Sci; 2015 Oct; 80(1):76-8. PubMed ID: 26254200
[No Abstract] [Full Text] [Related]
44. Compound heterozygosity for ARS component B mutations in a Dutch patient with mal de Meleda.
Nellen RG; van Geel M; Steijlen PM; van Steensel MA
Br J Dermatol; 2009 Apr; 160(4):878-80. PubMed ID: 19120323
[No Abstract] [Full Text] [Related]
45. Structural Diversity and Dynamics of Human Three-Finger Proteins Acting on Nicotinic Acetylcholine Receptors.
Paramonov AS; Kocharovskaya MV; Tsarev AV; Kulbatskii DS; Loktyushov EV; Shulepko MA; Kirpichnikov MP; Lyukmanova EN; Shenkarev ZO
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019770
[TBL] [Abstract][Full Text] [Related]
46. Nicotine induced modulation of SLURP-1 expression in human colon cancer cells.
Pettersson A; Nylund G; Khorram-Manesh A; Nordgren S; Delbro DS
Auton Neurosci; 2009 Jun; 148(1-2):97-100. PubMed ID: 19346165
[TBL] [Abstract][Full Text] [Related]
47. Further evidence of the clinical and genetic heterogeneity of recessive transgressive PPK in the Mediterranean region.
Charfeddine C; Mokni M; Kassar S; Zribi H; Bouchlaka C; Boubaker S; Rebai A; Ben Osman A; Abdelhak S
J Hum Genet; 2006; 51(10):841-845. PubMed ID: 16865292
[TBL] [Abstract][Full Text] [Related]
48. The first Mal de Meleda case in Libya: identification of a SLURP1 mutation.
Bchetnia M; Bozgia M; Laroussi N; Ben Brick AS; Charfeddine C; Ben Halim N; Mokni M; Boubaker MS; Abdelhak S
Int J Dermatol; 2015 Dec; 54(12):1426-8. PubMed ID: 24738704
[No Abstract] [Full Text] [Related]
49. Comment on Zhao et al. "Palmoplantar keratoderma of the Gamborg-Nielsen type is caused by mutations in the SLURP1 gene and represents a variant of Mal de Meleda".
Nellen RG; Steijlen PM; van Geel M; van Steensel MA
Acta Derm Venereol; 2015 Nov; 95(8):1034-5. PubMed ID: 26139149
[No Abstract] [Full Text] [Related]
50. Expression and function of genes encoding cholinergic components in murine immune cells.
Kawashima K; Yoshikawa K; Fujii YX; Moriwaki Y; Misawa H
Life Sci; 2007 May; 80(24-25):2314-9. PubMed ID: 17383684
[TBL] [Abstract][Full Text] [Related]
51. A Japanese case of Mal de Meleda with SLURP1 mutation.
Sakabe J; Kabashima-Kubo R; Kubo A; Sasaki T; Tokura Y
J Dermatol; 2014 Aug; 41(8):764-5. PubMed ID: 24985918
[No Abstract] [Full Text] [Related]
52. A hypomorphic Egfr allele does not ameliorate the palmoplantar keratoderma caused by SLURP1 deficiency.
Allan CM; Tran D; Tu Y; Heizer PJ; Young LC; Fong LG; Beigneux AP; Young SG
Exp Dermatol; 2017 Nov; 26(11):1134-1136. PubMed ID: 28418591
[TBL] [Abstract][Full Text] [Related]
53. SLURP-1, an endogenous α7 nicotinic acetylcholine receptor allosteric ligand, is expressed in CD205(+) dendritic cells in human tonsils and potentiates lymphocytic cholinergic activity.
Fujii T; Horiguchi K; Sunaga H; Moriwaki Y; Misawa H; Kasahara T; Tsuji S; Kawashima K
J Neuroimmunol; 2014 Feb; 267(1-2):43-9. PubMed ID: 24365495
[TBL] [Abstract][Full Text] [Related]
54. Reply to Nellen et al's comment on the classification of clinical/genetic variants of Mal de Meleda.
Zhao L; Vahlquist A; Virtanen M; Wennerstrand L; Lind LK; Lundström A; Pigg MH
Acta Derm Venereol; 2015 Nov; 95(8):1034-5. PubMed ID: 26844309
[No Abstract] [Full Text] [Related]
55. Genetically proven Mal de Meleda complicated by Bowen's disease of the sole.
Tourlaki A; Bentivogli M; Boneschi V; Brambilla L
Eur J Dermatol; 2011; 21(2):292-4. PubMed ID: 21382790
[No Abstract] [Full Text] [Related]
56. Heterozygous manifestations in female carriers of Mal de Meleda.
Mokni M; Charfeddine C; Ben Mously R; Baccouche D; Kaabi B; Ben Osman A; Dellagi K; Abdelhak S
Clin Genet; 2004 Mar; 65(3):244-6. PubMed ID: 14756676
[No Abstract] [Full Text] [Related]
57.
Jafar Hussain HM; Khan R; Li C; Aftab A; Muneer I; Wahab F; Wu L; Jiang X; Xu P
Ann Clin Lab Sci; 2019 Nov; 49(6):710-721. PubMed ID: 31882421
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases.
Chernyavsky AI; Arredondo J; Galitovskiy V; Qian J; Grando SA
Am J Physiol Cell Physiol; 2010 Nov; 299(5):C903-11. PubMed ID: 20660165
[TBL] [Abstract][Full Text] [Related]
59. [Mal de Meleda. 16 cases].
Marrakchi Z; Marrachi S; Meziou TJ; Turki H; Zahaf A
Tunis Med; 2006 Jul; 84(7):423-6. PubMed ID: 17039733
[TBL] [Abstract][Full Text] [Related]
60. Identification of a novel compound heterozygous mutation and a homozygous mutation of SLURP1 in Chinese families with Mal de Meleda.
Wang T; Tang Z; Xiao T; Ren J; He S; Liu Y; Xiao S; Wang X
BMC Med Genomics; 2023 Jul; 16(1):152. PubMed ID: 37393290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
